Hepatoprotective Effect of Thymoquinone Against Cadmium Induced Liver Toxicity in Wistar Rat by Inhibiting Reactive Oxygen Species

M. F. Alam
{"title":"Hepatoprotective Effect of Thymoquinone Against Cadmium Induced Liver Toxicity in Wistar Rat by Inhibiting Reactive Oxygen Species","authors":"M. F. Alam","doi":"10.19080/argh.2018.11.555822","DOIUrl":null,"url":null,"abstract":"The present study was designed to find out the hepatoprotective effect of Thymoquinone against cadmium induced liver toxicity in rat. Four different groups of rats were used for this study. In details Group-I was nornal rat; Group-II was toxic Cd (2 mg/kg/day) has given to rats subcutaneously for 7 days. Group-III was pre-treated with Thymoquinone and followed by Cd (2 mg/kg/day) for 7 days. Group-IV was given Thymoquinone (20 mg/kg/day) as a positive control for 7 days. At the end of experiment blood was taken for biochemical study (AST, ALT, ALP and Total Bilirubin) and thereafter animal was killed, and liver was dissected out to analyze oxidative stress (LPO, and GSH). The biochemical study indicated that the level of enzymes (AST, ALT, ALP and Total Bilirubin) was significantly (P≤0.01) elevated in the serum of Group-II and TBARS contents were also increased significantly in Group-II while the concentration of glutathione was significantly reduced in Cd induced (Group-II) as compared to normal control. When the rat was treated with Thymoquinone, TBARS content reduced significantly in Group-III and biochemical enzyme were also restored in Group-III while the glutathione (GSH) content increased as compared to Group-II. When alone Thymoquinone was given in Group-IV there was no any kind of biochemical enzyme elevation were found or neither no significant oxidative stress observed. In this way study indicated that Thymoquinone is effective for the treatment of liver diseases against heavy metal.","PeriodicalId":72074,"journal":{"name":"Advanced research in gastroenterology & hepatology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advanced research in gastroenterology & hepatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.19080/argh.2018.11.555822","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

The present study was designed to find out the hepatoprotective effect of Thymoquinone against cadmium induced liver toxicity in rat. Four different groups of rats were used for this study. In details Group-I was nornal rat; Group-II was toxic Cd (2 mg/kg/day) has given to rats subcutaneously for 7 days. Group-III was pre-treated with Thymoquinone and followed by Cd (2 mg/kg/day) for 7 days. Group-IV was given Thymoquinone (20 mg/kg/day) as a positive control for 7 days. At the end of experiment blood was taken for biochemical study (AST, ALT, ALP and Total Bilirubin) and thereafter animal was killed, and liver was dissected out to analyze oxidative stress (LPO, and GSH). The biochemical study indicated that the level of enzymes (AST, ALT, ALP and Total Bilirubin) was significantly (P≤0.01) elevated in the serum of Group-II and TBARS contents were also increased significantly in Group-II while the concentration of glutathione was significantly reduced in Cd induced (Group-II) as compared to normal control. When the rat was treated with Thymoquinone, TBARS content reduced significantly in Group-III and biochemical enzyme were also restored in Group-III while the glutathione (GSH) content increased as compared to Group-II. When alone Thymoquinone was given in Group-IV there was no any kind of biochemical enzyme elevation were found or neither no significant oxidative stress observed. In this way study indicated that Thymoquinone is effective for the treatment of liver diseases against heavy metal.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
胸腺醌通过抑制活性氧对镉诱导的Wistar大鼠肝毒性的保护作用
本研究旨在探讨百里醌对镉致大鼠肝毒性的保护作用。这项研究使用了四组不同的大鼠。1组为正常大鼠;ii组大鼠皮下注射Cd (2 mg/kg/天)7天。iii组采用百里醌预处理,随后给予Cd (2 mg/kg/d),连续7 d。iv组给予百里醌(20 mg/kg/d)作为阳性对照,连续7 d。实验结束后,取血进行AST、ALT、ALP、总胆红素生化分析,处死动物,解剖肝脏进行氧化应激(LPO、GSH)分析。生化试验表明,与正常对照组相比,ii组血清中AST、ALT、ALP和总胆红素水平显著(P≤0.01)升高,TBARS含量显著升高,而Cd诱导(ii组)血清中谷胱甘肽浓度显著降低。经百里醌处理后,iii组大鼠TBARS含量显著降低,生化酶恢复,谷胱甘肽(GSH)含量较ii组增加。iv组单独给予百里醌时,未见任何生化酶升高或氧化应激。研究表明,百里醌具有抗重金属治疗肝脏疾病的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Stage II/III Rectal Cancer Post-Treatment Surveillance Patterns of Care: A SEER- Medicare Study. Asymptomatic Colonic Metastases of Lung Cancer: A Case Report The Puborectal Muscle and External Anal Sphincter Can Act Independently of each other in Functional Defecation Disorders The Outcomes of Endoanal Ultrasound and Three-Dimensional, High-Resolution Anorectal Manometry do not Predict Fecal Incontinence Manometry in Chronic Anal Fissures: Clinical and Therapeutic Correlation
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1